12 completed, 12 unknown, 2 withdrawn, 1 enrolling by invitation. 30 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 30 | Completed 12, Unknown 12, Withdrawn 2, Enrolling by invitation 1, Recruiting 1, Suspended 1, Terminated 1 |
Follow Perindopril: new trials by email Literature Review of Perindopril trials Research Report on Perindopril
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD) Finerenone, Semaglutide, Lotensin - Chronic Kidney Disease, Type 2 Diabetes | Phase 4 | Enrolling by invitation | Baylor Research Institute | 64 | 2026-04-08 | 2026-10-13 |
| Timely Recovery After Subclinical Heart Failure Perindopril - Heart Failure, Diastolic Dysfunction | Phase 4 | Unknown | Academisch Ziekenhuis Maastricht | 130 | 2024-03-26 | 2024-04-02 |
| Early Treatment of ARNI on Myocardial Remodeling and Progress sacubitril/valsartan, perindopril, Cardiopulmonary Exercise Test - Myocardial Infarction | Phase 4 | Unknown | RenJi Hospital | 280 | 2020-05-01 | 2020-04-14 |
| Coronavirus (COVID-19) ACEi/ARB Investigation Thiazide or Thiazide-like diuretics, Calcium Channel Blockers, ACE inhibitor - Hypertension, COVID-19 | Phase 4 | Suspended | National University of Ireland, Galway, Ireland | 2414 | 2020-04-30 | 2020-06-30 |
| Effect of Atorvastatin on Carotid Intima Media Thickness Perindopril/Amlodipine and Perindopril/Amlodipine/Atorvastatin treatment - Essential Hypertension, Hypercholesterolemia | Phase 4 | Unknown | Yerevan State Medical University | 200 | 2020-04-15 | 2020-03-13 |
| Precision Treatment With Angiotensin Converting Enzyme Inhibitor genotyping and selection of renin-angiotensin system blocker, Perindopril - Hypertension | Phase 4 | Completed | Yonsei University | 77 | 2019-11-06 | 2023-01-11 |
| One Versus Twice Daily Administration of Multiple Cardiovascular Agents in Patients With Ischemic Heart Disease Aspirin, Atorvastatin, Perindopril - Ischemic Heart Disease | Phase 4 | Unknown | University of Roma La Sapienza | 100 | 2019-11-01 | 2019-11-05 |
| Moxonidine + Perindopril in Hypertensive Patients With Metabolic Syndrome perindopril + moxonidine - Arterial Hypertension, Metabolic Syndrome | Phase 4 | Unknown | Sergey V. Nedogoda | 120 | 2019-03-11 | 2019-07-23 |
| Safety and Efficacy of Two Year of RAAS Alone or in Combination With Spironolactone Therapy Renin-Angiotensin (RAAS) alone, Renin-Angiotensin (RAAS) blockers in combination with Spironolactone - Renal Insufficiency, Chronic, Diabetic Nephropathy Type 2 | Phase 4 | Unknown | James A. Tumlin, MD | 72 | 2018-10-01 | 2022-10-28 |
| Comparative Effects of Perindopril and Zofenopril on Blood Pressure Control and Oxidative Status Blacks Hypertensive Patients. Perindopril Arginine, Zofenopril, Calcium Salt, (1(R*),2Alpha,4Alpha)-isomer - Hypertension | Phase 4 | Completed | Yaounde Central Hospital | 24 | 2018-10-01 | 2020-02-05 |
| Evaluation of Losartan and Perindopril in Blacks Type 2 Diabetics Patients Perindopril Arginine, Losartan Potassium - Type 2 Diabetes Mellitus | Phase 4 | Completed | Yaounde Central Hospital | 23 | 2017-12-20 | 2020-01-10 |
| Fixed Combination for Lipid and Blood Pressure Control Atorvastatin, Amlodipine, Perindopril - Arterial Hypertension, Dyslipidemias | Phase 4 | Withdrawn | Charles University, Czech Republic | 2017-09-01 | 2019-06-21 | |
| Comparison of Three Combination Therapies in Lowering Blood Pressure in Black Africans Perindopril plus Amlodipine, Perindopril plus Hydrochlorothiazide, Amlodipine plus Hydrochlorothiazide - Hypertension | Phase 4 | Completed | University of Abuja | 702 | 2017-06-07 | 2021-08-24 |
| Once-daily Fixed Combination of Three Antihypertensive Drugs perindopril, indapamide , amlodipine, Tripliam (perindopril, indapamide, amlodipine) - Arterial Hypertension | Phase 4 | Unknown | University of Roma La Sapienza | 100 | 2016-04-01 | 2016-03-16 |
| Low-dose Combination of Three Antihypertensive Drugs Tripliam (perindopril, indapamide, amlodipine), Reaptan (perindopril, amlodipine) - Arterial Hypertension | Phase 4 | Unknown | University of Roma La Sapienza | 100 | 2016-04-01 | 2016-03-17 |
| NT-proBNP Selected Prevention of Cardiac Events in Diabetic Patients RAS-antagonist and beta-blocker up-to maximal dosages, RAS-antagonist and beta-blocker none or at stable dose - Heart Diseases, Diabetes Mellitus, Type 2 | Phase 4 | Recruiting | Martin Huelsmann | 2400 | 2016-02-01 | 2023-03-14 |
| Effect of Morning Versus Evening Perindopril on Blood Pressure Control in People With Type 2 Diabetes Perindopril Oral Tablet - Diabetes Mellitus, Type 2, Hypertension | Phase 4 | Completed | Yaounde Central Hospital | 20 | 2016-02-01 | 2018-01-08 |
| Chronic Angiotensin Converting Enzyme Inhibitors in Intermediate Risk Surgery ACEI continuation, ACEI omission - Hypotension on Induction | Phase 4 | Completed | University of Nebraska | 291 | 2015-06-01 | 2023-09-25 |
| Effect of Valsartan vs Perindopril on HOMA-IR Index in Patients With Chronic Kidney Disease Valsartan, Perindopril - Chronic Kidney Disease | Phase 4 | Unknown | Chinese PLA General Hospital | 60 | 2014-11-01 | 2014-12-02 |
| Perindopril and Telmisartan for the Treatment of Nonalcoholic Fatty Liver Disease Perindopril, Telmisartan, Amlodipine - Nonalcoholic Fatty Liver Disease (NAFLD) | Phase 4 | Unknown | Nanfang Hospital, Southern Medical University | 180 | 2014-08-01 | 2014-08-11 |
Showing 20 of 30. Sign in to see all of them.
Hypertension (16) · Diabetes Mellitus, Type 2 (4) · Renal Insufficiency, Chronic (4) · Heart Failure (2) · Albuminuria (1) · COVID-19 (1) · Cardiovascular Diseases (1) · Cerebral Small Vessel Diseases (1) · Coronary Artery Disease (1) · Coronavirus Infections (1) · Diabetes Mellitus (1) · Dyslipidemias (1) · Essential Hypertension (1) · Heart Diseases (1) · Hypercholesterolemia (1)
University of Roma La Sapienza (3) · Yaounde Central Hospital (3) · Academisch Ziekenhuis Maastricht (1) · Anna Posadzy-Małaczyńska (1) · Baylor Research Institute (1) · Cardiff University (1) · Charles University, Czech Republic (1) · Chinese PLA General Hospital (1) · Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company (1) · Hospices Civils de Lyon (1) · Imperial College London (1) · James A. Tumlin, MD (1) · Martin Huelsmann (1) · Medical University of Gdansk (1) · Monash University (1)
China (5) · Italy (3) · United Kingdom (3) · United States (3) · Cameroon (2) · France (2) · Netherlands (2) · Russia (2) · Spain (2) · Australia (1) · Austria (1) · Bulgaria (1) · Czechia (1) · Finland (1) · Ireland (1)
Carlo Gaudio, MD (2) · Bernard Geny, MD (1) · Bongani Mayosi, DPhil (1) · Christopher J Bulpitt, MD, FRCP (1) · Giuseppe Marazzi (1) · Hamayak Sisakian, MD (1) · Henry Krum, MBBS FRACP PhD (1) · Jason F Shiffermiller, MD, MPH (1) · John William McEvoy, MBBCh MHS (1) · Jun Ma, M.D,Ph.D (1) · Martin Huelsmann, Doz.Dr. (1) · Neil Poulter, MD, MSc (1)
PMID 18378519, PMID 18614402, PMID 19250558, PMID 20497949, PMID 20573778, PMID 21586342, PMID 22218098, PMID 22910302, PMID 23588194, PMID 24293132, PMID 24739801, PMID 24920166, PMID 25880068, PMID 27522394, PMID 27552643, PMID 30261084, PMID 30883050, PMID 31033362, PMID 34022790, PMID 34028812, PMID 37602458, PMID 3945351, PMID 6496469, PMID 8671821
2005 (1), 2009 (1)